Screener
Viridian Therapeutics, Inc. VRDN Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of common stock upon exercises of stock options | 6,934 | 3,060 |
| Proceeds from issuance of common stock under employee stock purchase plan | 1,270 | 561 |
| Net cash provided by financing activities | 331,478 | 9,976 |
| Net increase (decrease) in cash and cash equivalents | (47,396) | 17,730 |
| Cash and cash equivalents at beginning of period | 212,382 | 99,594 |
| Cash and cash equivalents at end of period | $164,986 | $117,324 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $2,227 | $905 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s net change in cash?
- Viridian Therapeutics, Inc. (VRDN) reported net change in cash of -$11.36M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s net change in cash changed year-over-year?
- Viridian Therapeutics, Inc.'s net change in cash decreased by 1124.3% year-over-year, from $1.11M to -$11.36M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Viridian Therapeutics, Inc.'s net change in cash has grown at a 459.9% compound annual growth rate (CAGR), from -$3.6M to $112.79M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Viridian Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude